McKesson

322 articles with McKesson

• McKesson’s Board of Directors Elects Linda Mantia as New Independent Director

  10/19/2020

  McKesson Corporation announced that the McKesson board of directors has elected Linda Mantia as an independent director and member of the board’s Audit and Governance Committees, effective Oct. 19, 2020.

• McKesson Ventures Grows Leadership Team with New Partner Promotions

  9/16/2020

  McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners of McKesson Ventures.

• 

  Biopharma Update on the Novel Coronavirus: August 17

  8/17/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.

• McKesson Canada Names Rebecca McKillican Chief Executive Officer

  8/10/2020

  McKesson Corporation announced the appointment of Rebecca McKillican as Chief Executive Officer, McKesson Canada effective immediately.

• McKesson Reports Fiscal 2021 First-Quarter Results

  8/3/2020

  Increased fiscal 2021 Adjusted Earnings per diluted share guidance range to $14.70 to $15.50, from the previous range of $13.95 to $14.75.

• McKesson Named One of the Best Places to Work for Disability Inclusion

  7/16/2020

  McKesson announced that The Disability Equality Index has named the company as one of its 2020 Best Places to Work for Disability Inclusion with a top-ranking score of 100.

• McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth

  7/1/2020

  McKesson Corporation announces changes to its reportable business structure.

• McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results

  5/20/2020

  McKesson Corporation reported results for the fourth quarter and fiscal year ended March 31, 2020.

• McKesson Appoints Lyn Fitzgerald as Vice President of Sales for McKesson Data, Evidence & Insights

  5/5/2020

  Industry veteran joins McKesson after more than 13 years at National Comprehensive Cancer Network

• McKesson Declares Quarterly Dividend April 29, 2020

  4/29/2020

  The Board of Directors of McKesson Corporation declared a regular dividend of 41 cents per share of common stock.

• McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020

  4/20/2020

  McKesson Corporation will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020.

• McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off

  3/17/2020

  McKesson Corporation announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020.

• McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer

  3/5/2020

  McKesson Corporation announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. common stock.

• McKesson Declares Quarterly Dividend payable on April 1, 2020

  1/29/2020

  The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 41 cents per share of common stock.

• McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook

  1/13/2020

  Brian Tyler, chief executive officer of McKesson, will provide a company overview and review topics including:

• Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture

  12/12/2019

  New entity combines wholesale operations to drive sustainable growth and deliver efficient distribution solutions for an evolving market

• McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer

  12/9/2019

  Flores to succeed Kathy McElligott who is retiring February 3, 2020

• McKesson Unveils Insight Into Hospital Pharmacy Trends and What Industry Can Expect in 2020

  12/9/2019

  Health system pharmacy experts stress partnerships and proactive use of data moving forward

• 

  Following Civil Settlements, Opioid Drugmakers and Distributors Could Face Criminal Charges

  11/27/2019

  The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.

• McKesson Reports Fiscal 2020 Second-Quarter Results

  10/30/2019

  McKesson Corporation reported results for the second quarter ended September 30, 2019.